Fig. 4From: An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotesDocked complex of TLR4 with vaccine construct. Accompanying structural monomers include second TLR4 ECD (TLR4*), MD-2 adapter and second adapter (MD-2*). Residual participants of receptor monomers interacting with vaccine (green) are represented by yellow (hydrophobic) and red (hydrogen bond) CPK shapesBack to article page